The "Single-use Technologies for Biopharmaceuticals Market" report has been added to ResearchAndMarkets.com's offering. The Single-use Technologies for Biopharmaceuticals was valued at USD 6.5 billion ...
CDMO’s new site introducing the most advanced and large-scale single-use bioreactors in the region According to 2024 data from BDO Group's bioTRAK Database, single-use technology represents 51 percent ...
SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and ...
Join us at HIMSS26, the premier event that brings together healthcare professionals, technology partners, policymakers and thought leaders for four days of learning, collaboration and inspiration.
Single-use technologies (SUT) are well-suited for modular production environments and represent a valuable solution in today’s ever-evolving biologics development landscape. Though SUTs have been ...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new research paper from its global research and development Center (R&D ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today opened its largest single-use technology manufacturing site in Greater Nashville. The $105 ...
The "Single Use Bioreactors Market Industry Trends and Global Forecasts to 2035, by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, ...
2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to more sustainable technologies, the forces driving change are redefining how therapies are discovered, ...
Biopharmaceutical production requires a lot of energy and materials and creates a significant amount of plastic waste. Finding ways to make it more sustainable is vital from both an environmental and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results